From: Nonmuscle Myosin II helps regulate synaptic vesicle mobility at the Drosophilaneuromuscular junction
Treatment | Rate Parameters1 | |||
---|---|---|---|---|
 | A | K1 | B | K2 |
Vesicle Mobility | Â | Â | Â | Â |
0 μM ML-9 | 0.38 ± 0.031 | 0.0040 ± 0.0010 | 0.72 ± 0.031 | 0.11 ± 0.40 |
10 μM ML-9 | 0.37 ± 0.0035 | 0.0035 ± 0.0010 | 0.40 ± 0.083 | 0.080 ± 0.023 |
50 μM ML-9 | 0.39 ± 0.030 | 0.0025 ± 0.0010 | 0.42 ± 0.087 | 0.080 ± 0.022 |
100 μM ML-9 | 0.51 ± 0.020 | 0.0025 ± 0.0005 | 0.29 ± 0.16 | 0.11 ± 0.050 |
Control (ct) | 0.40 ± 0.033 | 0.0047 ± 0.0012 | 0.58 ± 0.22 | 0.10 ± 0.039 |
Heterozygous Loss-of-Function (Het) | 0.37 ± 0.043 | 0.0069 ± 0.0015 | 0.66 ± 0.33 | 0.12 ± 0.049 |
RNAi Knockdown (K/D) | 0.46 ± 0.035 | 0.0031 ± 0.0008 | 0.28 ± 0.12 | 0.082 ± 0.045 |
Overexpression (O/E) | 0.49 ± 0.040 | 0.0023 ± 0.0010 | 0.35 ± 0.093 | 0.071 ± 0.030 |